Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $520
J.P. Morgan Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $575
JPMorgan Adjusts Price Target on IDEXX Laboratories to $575 From $630
IDEXX Labs Is Maintained at Hold by Stifel
IDEXX Laboratories Analyst Ratings
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $500
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $589
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $550
BTIG Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $580
IDEXX Laboratories Analyst Ratings
BNP Paribas Exane Adjusts Price Target on IDEXX Laboratories to $607 From $641
Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $520
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $550
Barclays Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $570
Barclays Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $570
Analyst Ratings For IDEXX Laboratories
IDEXX Labs Price Target Announced at $580.00/Share by BTIG
IDEXX Laboratories Analyst Ratings
BTIG Initiates IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Announces Target Price $580
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $589 From $596, Maintains Overweight Rating
No Data
No Data